Cargando…
Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome crit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146870/ https://www.ncbi.nlm.nih.gov/pubmed/35629260 http://dx.doi.org/10.3390/jpm12050838 |
_version_ | 1784716668756295680 |
---|---|
author | Mishima, Takayasu Fujioka, Shinsuke Kawazoe, Miki Inoue, Kotoe Arima, Hisatomi Tsuboi, Yoshio |
author_facet | Mishima, Takayasu Fujioka, Shinsuke Kawazoe, Miki Inoue, Kotoe Arima, Hisatomi Tsuboi, Yoshio |
author_sort | Mishima, Takayasu |
collection | PubMed |
description | Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome criteria (Rome III), which has been validated and the widely used for gastrointestinal disorders. Fifty-one patients with MSA (29 female) were enrolled in the study. Based on the Rome III criteria, constipation was diagnosed in 29 patients (56.9%); irritable bowel syndrome was not detected. Thirty-seven patients (72.5%) were aware of their constipation. The most common constipation symptom was the sensation of anorectal obstruction (68.6%). Patients’ self-awareness of constipation was most strongly correlated to the sensation of incomplete evacuation (odds ratio: 7.377, 95% confidence interval: 1.402–38.817). The number of constipation-related symptoms was correlated with the total levodopa equivalent dose (p < 0.05). Rome criteria, which can detect various constipation symptoms, are useful for evaluating constipation in MSA, and these findings may greatly impact personalized medicine. |
format | Online Article Text |
id | pubmed-9146870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91468702022-05-29 Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine Mishima, Takayasu Fujioka, Shinsuke Kawazoe, Miki Inoue, Kotoe Arima, Hisatomi Tsuboi, Yoshio J Pers Med Article Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome criteria (Rome III), which has been validated and the widely used for gastrointestinal disorders. Fifty-one patients with MSA (29 female) were enrolled in the study. Based on the Rome III criteria, constipation was diagnosed in 29 patients (56.9%); irritable bowel syndrome was not detected. Thirty-seven patients (72.5%) were aware of their constipation. The most common constipation symptom was the sensation of anorectal obstruction (68.6%). Patients’ self-awareness of constipation was most strongly correlated to the sensation of incomplete evacuation (odds ratio: 7.377, 95% confidence interval: 1.402–38.817). The number of constipation-related symptoms was correlated with the total levodopa equivalent dose (p < 0.05). Rome criteria, which can detect various constipation symptoms, are useful for evaluating constipation in MSA, and these findings may greatly impact personalized medicine. MDPI 2022-05-20 /pmc/articles/PMC9146870/ /pubmed/35629260 http://dx.doi.org/10.3390/jpm12050838 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mishima, Takayasu Fujioka, Shinsuke Kawazoe, Miki Inoue, Kotoe Arima, Hisatomi Tsuboi, Yoshio Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine |
title | Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine |
title_full | Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine |
title_fullStr | Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine |
title_full_unstemmed | Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine |
title_short | Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine |
title_sort | constipation symptoms in multiple system atrophy using rome criteria and their impact on personalized medicine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146870/ https://www.ncbi.nlm.nih.gov/pubmed/35629260 http://dx.doi.org/10.3390/jpm12050838 |
work_keys_str_mv | AT mishimatakayasu constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine AT fujiokashinsuke constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine AT kawazoemiki constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine AT inouekotoe constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine AT arimahisatomi constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine AT tsuboiyoshio constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine |